Publications by authors named "Dan Hartman"

Claim this Profile
I
Intravascular Lymphoma Presenting as Multiple Endocrine Failure, Transforming Into the Hemophagocytic Variant, and Relapsing as a Thrombotic Microangiopathy.
Nigel P Murray, Cinthia Escobar, Enrique Ramos, Claudia Perez, Dan Hartman

Case Rep Hematol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Test of Autonomy Restoration Postscripts to Mitigate Psychological Reactance to an Opt-Out Organ Donor Registry in the United States.
Brian L Quick, Lauren A Kriss, Ethan Morrow, Dan Hartman, Brenda Koester

Health Commun· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lessons from the pandemic: Responding to emerging zoonotic viral diseases-a Keystone Symposia report.
Jennifer Cable, Anthony Fauci, William E Dowling, Stephan Günther, Dennis A Bente, Dan Hartman

Ann N Y Acad Sci· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Application of exposure bracketing to streamline the development of contraceptive products.
Joshua Brown, Tamra Goodrow, Dan Hartman, Justin L Hay, Kevin Hershberger

Contracept X· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eight years of the East African Community Medicines Regulatory Harmonization initiative: Implementation, progress, and lessons learned.
Jane H Mashingia, Vincent Ahonkhai, Noel Aineplan, Aggrey Ambali, Apollo Angole, Dan Hartman

PLoS Med· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Time to Step Up: A Call to Action For the Clinical and Quantitative Pharmacology Community to Accelerate Therapeutics for COVID-19.
Dan Hartman, Steven Kern, Fran Brown, Suzanne K Minton, Craig R Rayner

Clin Transl Sci· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Scientific considerations for global drug development.
Jennifer L Wilson, Kit Wun Kathy Cheung, Lawrence Lin, Elizabeth A E Green, Analia I Porrás, Dan Hartman

Sci Transl Med· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical trials in the pandemic age: What is fit for purpose?
Dan Hartman, Penny Heaton, Nick Cammack, Ian Hudson, Shawn Dolley

Gates Open Res· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
What's Past Is Prologue: Clinical Pharmacology at the Intersection of Science, Policy, and Patients.
Issam Zineh, Dan Hartman

Clin Pharmacol Ther· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Patient-Centered Future of Clinical Pharmacology.
Mohamed H Shahin, Susan Abdel-Rahman, Dan Hartman, Julie A Johnson, David Y Mitchell

Clin Pharmacol Ther· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug-Drug Interactions of Infectious Disease Treatments in Low-Income Countries: A Neglected Topic?
Savannah J McFeely, Jingjing Yu, Ping Zhao, Susan Hershenson, Steven Kern, Dan Hartman

Clin Pharmacol Ther· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Model-Informed Assessment of Anti-Infectives for Young Children in Low- and Middle-Income Countries.
Ping Zhao, Jonathan Arm, Lyou-Fu Ma, Stephen Ward, David Hermann, Dan Hartman

CPT Pharmacometrics Syst Pharmacol· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Speeding Access to Vaccines and Medicines in Low- and Middle-Income Countries: A Case for Change and a Framework for Optimized Product Market Authorization.
Vincent Ahonkhai, Samuel F Martins, Alexandre Portet, Murray Lumpkin, Dan Hartman

PLoS One· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Poor medication adherence in clinical trials: consequences and solutions.
Alasdair Breckenridge, Jeffrey K Aronson, Terrence F Blaschke, Dan Hartman, Carl C Peck

Nat Rev Drug Discov· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DG-041 inhibits the EP3 prostanoid receptor--a new target for inhibition of platelet function in atherothrombotic disease.
Stan Heptinstall, David Iyu Espinosa, Panagiotis Manolopoulos, Jackie R Glenn, Ann E White, Dan Hartman

Platelets· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis